Why Consumers are Increasing Luxury Spending

 

What better time to run a quick spending spree than right after the fall of Covid? As the world recovers from the pandemic, a surprising trend has emerged – consumers are increasing their luxury spending despite the overall reluctance to spend. A recent survey by Criteo, an online advertising firm, found this trend across all income levels. So, what is driving this trend, and can it continue?

According to a report by McKinsey & Company, the pandemic has created a K-shaped recovery, with the top 20% of earners seeing their wealth increase while the bottom 80% have experienced a decline. This has resulted in a surge in luxury spending, with consumers using their extra cash from stimulus checks and curve spending from shutdowns to purchase high-end products and experiences.

In addition, luxury brands have become more accessible to consumers, thanks to the rise of digital shopping channels and social media marketing. Brands are investing in these platforms to access Gen Z consumers who are not yet financially independent but are expected to become valuable consumers in the future.

However, this trend may not be sustainable in the long run. The report by McKinsey & Company suggests that if macro conditions remain uncertain, the 80% of luxury clientele who are nearly wealthy or aspirational may pull back. On the other hand, the remaining 20% who are ultra or very wealthy make up the majority of sales, indicating that luxury spending may continue to be resilient in relation to the broader retail landscape.

Here’s what Chelsea Zhang, Vice President at Equal Ventures, has to say on luxury spending:

Chelsea Zhang’s Thoughts:

“Consumers of all income levels exit the pandemic with a ton of extra cash from stimulus checks or curve spending from shutdowns. Revenge spending was rampant. Consumers embraced a “life is too short” attitude and unleashed pent-up demand for luxury products and experiences. Luxury itself has also become way more accessible.

Luxury markets are pushing into digital shopping channels or investing in social media to access the Gen Z consumers who don’t have the buying power right now but will age into incredibly valuable consumers. Going forward, if macro conditions remain uncertain, the 80% of luxury clientele who are nearly wealthy or aspirational will pull back.

The remaining 20% who are ultra or very wealthy do make up the vast majority of sales, so luxury market will likely remain relatively resilient in relation to the broader retail landscape.”

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More